Cargando…

Screening Intervals for Diabetic Retinopathy and Implications for Care

PURPOSE OF REVIEW: The purpose of this study is to review the evidence that lower risk groups who could safely be screened less frequently for sight-threatening diabetic retinopathy (DR) than annually. RECENT FINDINGS: Data have demonstrated that people with no DR in either eye are at a low risk of...

Descripción completa

Detalles Bibliográficos
Autor principal: Scanlon, Peter H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585285/
https://www.ncbi.nlm.nih.gov/pubmed/28875458
http://dx.doi.org/10.1007/s11892-017-0928-6
_version_ 1783261590623092736
author Scanlon, Peter H.
author_facet Scanlon, Peter H.
author_sort Scanlon, Peter H.
collection PubMed
description PURPOSE OF REVIEW: The purpose of this study is to review the evidence that lower risk groups who could safely be screened less frequently for sight-threatening diabetic retinopathy (DR) than annually. RECENT FINDINGS: Data have demonstrated that people with no DR in either eye are at a low risk of progression to sight-threatening DR over a 2-year period (event rate 4.8 per 1000 person years), irrespective of whether the screening method is one-field non-mydriatic or two-field mydriatic digital photography. Low risk has been defined as no retinopathy on two consecutive screening episodes or no retinopathy on one screening episode combined with risk factor data. SUMMARY: The risk of an extension to 2 years is less than 5 per 1000 person years in a population with a national screening programme, and the general standard of diabetes care is relatively good, whether low risk is defined as no retinopathy on two consecutive screening episodes or no retinopathy on one screening episode combined with other risk factor data. The definition used in different populations is likely to depend on the availability of data.
format Online
Article
Text
id pubmed-5585285
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-55852852017-09-20 Screening Intervals for Diabetic Retinopathy and Implications for Care Scanlon, Peter H. Curr Diab Rep Microvascular Complications—Retinopathy (JK Sun and PS Silva, Section Editors) PURPOSE OF REVIEW: The purpose of this study is to review the evidence that lower risk groups who could safely be screened less frequently for sight-threatening diabetic retinopathy (DR) than annually. RECENT FINDINGS: Data have demonstrated that people with no DR in either eye are at a low risk of progression to sight-threatening DR over a 2-year period (event rate 4.8 per 1000 person years), irrespective of whether the screening method is one-field non-mydriatic or two-field mydriatic digital photography. Low risk has been defined as no retinopathy on two consecutive screening episodes or no retinopathy on one screening episode combined with risk factor data. SUMMARY: The risk of an extension to 2 years is less than 5 per 1000 person years in a population with a national screening programme, and the general standard of diabetes care is relatively good, whether low risk is defined as no retinopathy on two consecutive screening episodes or no retinopathy on one screening episode combined with other risk factor data. The definition used in different populations is likely to depend on the availability of data. Springer US 2017-09-05 2017 /pmc/articles/PMC5585285/ /pubmed/28875458 http://dx.doi.org/10.1007/s11892-017-0928-6 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Microvascular Complications—Retinopathy (JK Sun and PS Silva, Section Editors)
Scanlon, Peter H.
Screening Intervals for Diabetic Retinopathy and Implications for Care
title Screening Intervals for Diabetic Retinopathy and Implications for Care
title_full Screening Intervals for Diabetic Retinopathy and Implications for Care
title_fullStr Screening Intervals for Diabetic Retinopathy and Implications for Care
title_full_unstemmed Screening Intervals for Diabetic Retinopathy and Implications for Care
title_short Screening Intervals for Diabetic Retinopathy and Implications for Care
title_sort screening intervals for diabetic retinopathy and implications for care
topic Microvascular Complications—Retinopathy (JK Sun and PS Silva, Section Editors)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585285/
https://www.ncbi.nlm.nih.gov/pubmed/28875458
http://dx.doi.org/10.1007/s11892-017-0928-6
work_keys_str_mv AT scanlonpeterh screeningintervalsfordiabeticretinopathyandimplicationsforcare